We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+12.31%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$33.4B
AUM Growth
+$2.35B
Cap. Flow
-$652M
Cap. Flow %
-1.96%
Top 10 Hldgs %
25.9%
Holding
1,133
New
72
Increased
394
Reduced
425
Closed
76

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$242M
2
AMZN icon
Amazon
AMZN
+$69.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$67M
4
UBS icon
UBS Group
UBS
+$59.2M
5
LW icon
Lamb Weston
LW
+$58.5M

Top Sells

Rank Stock Value
1
AXNX
Axonics, Inc. Common Stock
AXNX
+$105M
2
AAPL icon
Apple
AAPL
+$87.1M
3
APTV icon
Aptiv
APTV
+$80.3M
4
TSCO icon
Tractor Supply
TSCO
+$80M
5
DE icon
Deere & Co
DE
+$78.5M

Sector Composition

Rank Sector Weight
1 Technology 35.56%
2 Healthcare 16.52%
3 Consumer Discretionary 11.68%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TJX icon
26
TJX Companies
TJX
$180B
$217M 0.65%
2,134,836
+133,897
+7% +$13M
TSLA icon
27
Tesla
TSLA
$1.2T
$204M 0.61%
1,159,820
-70,935
-6% -$13.9M
ABBV icon
28
AbbVie
ABBV
$471B
$202M 0.6%
1,107,760
+40,675
+4% +$7.01M
AMD icon
29
Advanced Micro Devices
AMD
$714B
$201M 0.6%
1,113,319
-29,561
-3% -$5.17M
PANW icon
30
Palo Alto Networks
PANW
$257B
$200M 0.6%
1,406,092
+33,704
+2% +$5.32M
ZTS icon
31
Zoetis
ZTS
$32.7B
$199M 0.6%
1,175,215
+118,819
+11% +$22.3M
AXP icon
32
American Express
AXP
$226B
$198M 0.59%
867,796
-5,529
-0.6% -$1.15M
ADP icon
33
Automatic Data Processing
ADP
$111B
$197M 0.59%
788,474
+41,923
+6% +$10.2M
CSCO icon
34
Cisco
CSCO
$450B
$196M 0.59%
3,917,737
+200,926
+5% +$10M
ADBE icon
35
Adobe
ADBE
$105B
$192M 0.58%
380,134
-38,527
-9% -$22.1M
ETN icon
36
Eaton
ETN
$142B
$192M 0.57%
613,419
+47,852
+8% +$13.1M
LIN icon
37
Linde
LIN
$236B
$192M 0.57%
412,779
+25,866
+7% +$11.2M
ADSK icon
38
Autodesk
ADSK
$52.4B
$167M 0.5%
641,553
+28,779
+5% +$7.28M
AMGN icon
39
Amgen
AMGN
$211B
$165M 0.5%
581,369
-5,350
-0.9% -$1.57M
MA icon
40
Mastercard
MA
$500B
$162M 0.49%
336,085
+18,011
+6% +$8.23M
BSX icon
41
Boston Scientific
BSX
$69.2B
$159M 0.48%
2,319,391
-138,698
-6% -$8.92M
NXPI icon
42
NXP Semiconductors
NXPI
$62.6B
$158M 0.47%
638,780
+290,206
+83% +$67M
TSM icon
43
TSMC
TSM
$1.98T
$157M 0.47%
1,151,735
+7,463
+0.7% +$927K
MRK icon
44
Merck
MRK
$324B
$154M 0.46%
1,167,694
-136,922
-10% -$16.9M
TXN icon
45
Texas Instruments
TXN
$251B
$153M 0.46%
877,312
-42,185
-5% -$7.03M
ACN icon
46
Accenture
ACN
$107B
$150M 0.45%
432,522
+31,207
+8% +$11.4M
JPM icon
47
JPMorgan Chase
JPM
$929B
$147M 0.44%
735,848
+118,479
+19% +$21.4M
UBER icon
48
Uber
UBER
$144B
$144M 0.43%
1,872,754
-52,777
-3% -$3.79M
PCAR icon
49
PACCAR
PCAR
$71.5B
$142M 0.43%
1,148,834
-129,180
-10% -$13.9M
GILD icon
50
Gilead Sciences
GILD
$167B
$142M 0.43%
1,939,407
+127,661
+7% +$9.82M

Similar funds

Axa's Q1 2024 Portfolio in Review

As of Q1 2024, Axa held 1,133 positions worth $33.4B, up 7.6% from $31B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Axa's Q1 2024 filing shows 72 new, 394 increased, 425 reduced and 76 closed positions. Its largest new stake was Lamb Weston: 561,708 shares worth $59.8M. The largest sale was Axonics, Inc. Common Stock, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q1 2024 buy was Lamb Weston: 561,708 shares worth $59.8M.
  • Axa added most to Meta Platforms (Facebook) in Q1 2024, an estimated $242M increase.
  • Axa's biggest Q1 2024 reduction was Axonics, Inc. Common Stock, cutting an estimated $105M.
  • Axa fully exited Archer Daniels Midland in Q1 2024, selling an estimated $53.4M.
  • Axa's ten largest holdings make up 26% of its $33.4B portfolio in Q1 2024.
  • Axa opened 72 new positions and closed 76 in Q1 2024.
  • Axa's portfolio value rose 7.6% quarter-over-quarter to $33.4B.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.